Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?
Corvus Pharmaceuticals Ownership Summary
Corvus Pharmaceuticals is owned by 45.01% institutional investors, 4.02% insiders, and 50.97% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.16% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.46% of its assets in Corvus Pharmaceuticals shares.
CRVS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Corvus Pharmaceuticals | 45.01% | 4.02% | 50.97% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 6.94M | 14.16% | $12.64M |
| Samlyn capital | 6.12M | 12.49% | $11.14M |
| Point72 asset management | 5.96M | 12.16% | $10.86M |
| Adams street partners | 3.28M | 6.68% | $5.96M |
| Vanguard group | 1.65M | 3.37% | $3.00M |
| Renaissance | 563.93K | 1.15% | $1.03M |
| Blackrock | 562.02K | 1.15% | $1.02M |
| Geode capital management | 460.14K | 0.94% | $837.62K |
| Towerview | 400.00K | 0.82% | $728.00K |
| Morgan stanley | 371.40K | 0.76% | $675.95K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Adams street partners | 3.28M | 2.46% | $5.96M |
| Towerview | 400.00K | 0.48% | $728.00K |
| Orbimed advisors | 6.94M | 0.25% | $12.64M |
| Samlyn capital | 6.12M | 0.19% | $11.14M |
| Masso torrence wealth management | 30.00K | 0.08% | $160.50K |
| Jackson square capital | 63.77K | 0.08% | $341.19K |
| Three bridge wealth advisors | 22.37K | 0.04% | $119.69K |
| Point72 asset management | 5.96M | 0.03% | $10.86M |
| Avity investment management | 29.68K | 0.01% | $158.79K |
| Western pacific wealth management, lp | 2.00K | 0.01% | $10.70K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 5.96M | 0.03% | 5.96M |
| Samlyn capital | 6.12M | 0.19% | 3.77M |
| Millennium management | 204.60K | 0.00% | 181.32K |
| Vanguard group | 1.65M | 0.00% | 157.14K |
| Morgan stanley | 371.40K | 0.00% | 96.04K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | - | - | -361.41K |
| Bridgeway capital management | 127.30K | 0.01% | -97.00K |
| Renaissance | 563.93K | 0.00% | -73.10K |
| Two sigma advisers, lp | 113.40K | 0.00% | -71.70K |
| Two sigma investments, lp | 47.79K | 0.00% | -54.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 5.96M | 0.03% | 5.96M | $10.86M |
| Marshall wace, llp | 74.56K | 0.00% | 74.56K | $135.70K |
| Cubist systematic strategies | 24.36K | 0.00% | 24.36K | $44.34K |
| Three bridge wealth advisors | 22.37K | 0.04% | 22.37K | $119.69K |
| China universal asset management | 13.63K | 0.01% | 13.63K | $72.89K |
Sold Out
| Holder | Change |
|---|---|
| Ica group wealth management | -165.00 |
| Wells fargo & company/mn | -265.00 |
| Qube research | -2.38K |
| Group one trading | -4.60K |
| Fortem financial group | -11.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 70 | 40.00% | 30,020,596 | 8.80% | 45 | 1.42% | 38 | 100.00% | 10 | - |
| Jun 30, 2024 | 50 | - | 27,591,708 | 54.15% | 56 | 4.22% | 19 | - | 10 | -23.08% |
| Mar 31, 2024 | 50 | - | 17,899,766 | -6.69% | 36 | 2.38% | 19 | 35.71% | 13 | 18.18% |
| Dec 31, 2023 | 50 | -10.71% | 19,183,314 | -0.02% | 39 | 2.40% | 14 | -41.67% | 11 | -8.33% |
| Sep 30, 2023 | 56 | - | 19,186,336 | -1.57% | 40 | 2.30% | 24 | -31.43% | 12 | 100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.58M | 2.46% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 793.14K | 1.23% | 21.24K |
| iShares Biotechnology ETF | 323.11K | 0.50% | -2.33K |
| Fidelity Extended Market Index | 278.27K | 0.43% | -1.83K |
| Bridgeway Ultra-Small Company Market | 123.70K | 0.20% | - |
| BlackRock Extended Equity Market K | 104.43K | 0.17% | 30.20K |
| Extended Equity Market Fund K | 103.01K | 0.16% | -1.42K |
| iShares Micro-Cap ETF | 96.29K | 0.15% | - |
| Fidelity Total Market Index | 91.00K | 0.14% | - |
| iShares Core S&P Total US Stock Mkt ETF | 73.23K | 0.11% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 06, 2024 | Thompson Peter A. | Buy | $4.89M | |
| May 06, 2024 | Thompson Peter A. | Buy | $144.41 | |
| May 06, 2024 | ORBIMED ADVISORS LLC | Buy | $144.41 | |
| May 06, 2024 | ORBIMED ADVISORS LLC | Buy | $4.89M | |
| May 06, 2024 | Jones William Benton | See Remarks | Buy | $34.62K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | 8 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q2 | 1 | - |
| 2023 Q1 | - | - |
CRVS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools